BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 352939)

  • 21. Immunization against retrograde pyelonephritis. III. Vaccination against chronic pyelonephritis due to Escherichia coli.
    Brooks SJ; Lyons JM; Braude AI
    J Infect Dis; 1977 Nov; 136(5):633-9. PubMed ID: 335001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preliminary results of the vaccine treatment of chronic pyelonephritis in animal experiments].
    Straube E; Broschewitz U; Schill H; Naumann G
    Z Urol Nephrol; 1984 Jul; 77(7):401-5. PubMed ID: 6385543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
    Straube E; Naumann G; Broschewitz U
    Z Urol Nephrol; 1988 Apr; 81(4):247-55. PubMed ID: 3041706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of pyelonephritis by immunization with P-fimbriae.
    Roberts JA; Hardaway K; Kaack B; Fussell EN; Baskin G
    J Urol; 1984 Mar; 131(3):602-7. PubMed ID: 6199527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of immunization with K1-antigen of Escherichia coli on the course of experimental urinary tract infection in the rat].
    Straube E; Nimmich W; Broschewitz U; Naumann G
    Z Urol Nephrol; 1986 Jun; 79(6):335-46. PubMed ID: 3529745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Production of O antigens and antibodies during urinary tract infections due to Escherichia coli (author's transl)].
    Fries D; Renault L; Mathieu D; Charpentier B; Guerin D; Jacques L
    Nouv Presse Med; 1979 Mar; 8(15):1239-43. PubMed ID: 375188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of antibody-coated bacteria in urinary sediment in experimental pyelonephritis.
    Smith JW; Jones SR; Kaijser B
    J Infect Dis; 1977 Apr; 135(4):577-81. PubMed ID: 323377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective capacity of antibodies against Escherichia coli and K antigens.
    Kaijser B; Ahlstedt S
    Infect Immun; 1977 Aug; 17(2):286-9. PubMed ID: 70410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local immune response to lipoprotein of the outer membrane of Escherichia coli in experimental pyelonephritis.
    Smith JW
    Infect Immun; 1977 Aug; 17(2):366-70. PubMed ID: 330406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
    Pecha B; Low D; O'Hanley P
    J Clin Invest; 1989 Jun; 83(6):2102-8. PubMed ID: 2566625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):345-58. PubMed ID: 4590645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.
    Smith JW; Kaijser B
    J Clin Invest; 1976 Aug; 58(2):276-81. PubMed ID: 783196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
    Roberts JA; Kaack MB; Baskin G; Chapman MR; Hunstad DA; Pinkner JS; Hultgren SJ
    J Urol; 2004 Apr; 171(4):1682-5. PubMed ID: 15017266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of Escherichia coli antibodies in urinary tract infection: a review and perspective.
    Neter E
    Kidney Int Suppl; 1975 Aug; 4():S23-7. PubMed ID: 1104978
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of active and passive immunization on the development of experimental Pseudomonas aeruginosa pyelonephritis in mice.
    Petit JC; Sicard D; Bayo S; Daguet GL
    Can J Microbiol; 1981 Jan; 27(1):93-7. PubMed ID: 6783287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Local immunity -- a protection against experimental pyelonephritis].
    Kaijser B
    Lakartidningen; 1979 Oct; 76(40):3403-4. PubMed ID: 388121
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental Escherichia coli 06 infection in mice. 1. Effect of immunisation on resistance in relation to 06 antibody levels in mice of different strains.
    Ahlstedt S
    Acta Pathol Microbiol Scand C; 1980 Feb; 88(1):39-45. PubMed ID: 6990690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal immunization with P fimbriae for the prevention of neonatal pyelonephritis.
    Kaack MB; Roberts JA; Baskin G; Patterson GM
    Infect Immun; 1988 Jan; 56(1):1-6. PubMed ID: 2891616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to Escherichia coli K and O antigens in protection against acute pyelonephritis.
    Kaijser B; Larsson P; Nimmich W; Söderström T
    Prog Allergy; 1983; 33():275-88. PubMed ID: 6187016
    [No Abstract]   [Full Text] [Related]  

  • 40. [Modification by cyclophosphamide of the effect of autovaccination in chronic pyelonephritis in an animal experiment].
    Straube E; Broschewitz U; Nimmich W; Naumann G; Hacker K
    Z Urol Nephrol; 1987 Jun; 80(6):353-63. PubMed ID: 3307215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.